Managing a Locally Advanced Cervix Cancer Patient With COVID-19: Lessons Learned.
brachytherapy
cervix cancer
chemotherapy
covid-19
radiotherapy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
30 Aug 2020
30 Aug 2020
Historique:
entrez:
2
10
2020
pubmed:
3
10
2020
medline:
3
10
2020
Statut:
epublish
Résumé
We present the case of a woman diagnosed with coronavirus disease 2019 (COVID-19) while undergoing chemoradiation for locally advanced cervix cancer. This diagnosis had implications for the treatment of her cancer, and a number of important decisions had to be made. We present the issues that arose and how her oncologic care was managed.
Identifiants
pubmed: 33005550
doi: 10.7759/cureus.10138
pmc: PMC7524020
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e10138Informations de copyright
Copyright © 2020, D'Souza et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Oncotarget. 2017 Jul 27;8(49):85203-85213
pubmed: 29156713
Int J Gynecol Cancer. 2020 May;30(5):561-563
pubmed: 32221023
Oncologist. 2020 Jun;25(6):e936-e945
pubmed: 32243668
Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1275-88
pubmed: 7635767